USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CALISTA THERAPEUTICS, INC.
Address:
32 RIVERSIDE DR
LINCOLN, RI 02865-1511
Phone:
(401) 345-5979
URL:
N/A
EIN:
145540950
DUNS:
078513201
Number of Employees:
1
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $224,993.00 1

Award List:

An Automated Platform for High-throughput Network Electrophysiology

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$224,993.00
Agency:
HHS
Principal Investigator:
Alvin Bach – 401-345-5979
Abstract:
DESCRIPTION (provided by applicant): Calista Therapeutics has discovered a first-in-class, proprietary PDZ1-2 lead drug, AT010, that is being optimized and developed as an inhaled daily therapy for cystic fibrosis (CF). CF is a deadly inherited genetic disorder that disrupts chloride channel… More